Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

NCT00004857 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: alemtuzumab
DRUG: fludarabine phosphate

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]